SCHEMBL5042973

SCHEMBL5042973

CS(=O)(=O)c1ccc(OCC2CC2)c(C(=O)N2CCN(c3ccc(C(F)(F)F)cn3)CC2)c1

nearest known ligand 0.78

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 17/20 0.78
KCNH2 Q12809 7/20 0.72
SLC6A5 Q9Y345 2/20 0.72
KDM4E B2RXH2 2/20 0.57
LMNA P02545 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
GPR119 Q8TDV5 1/20 0.54
HTT P42858 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5038162 0.90 SLC6A9 (0.78) SLC6A9KCNH2SLC6A5GPR119
SCHEMBL5047808 0.90 SLC6A9 (0.77) SLC6A9KCNH2SLC6A5KDM4ELMNA
SCHEMBL4433387 0.88 SLC6A9 (1.00) SLC6A9KCNH2SLC6A5
SCHEMBL5045308 0.88 SLC6A9 (0.67) SLC6A9KCNH2SLC6A5GPR119
SCHEMBL5042963 0.87 SLC6A9 (0.73) SLC6A9KCNH2SLC6A5
SCHEMBL4432895 0.86 SLC6A9 (0.75) SLC6A9KCNH2SLC6A5KDM4ELMNA
SCHEMBL5047471 0.86 SLC6A9 (0.77) SLC6A9KCNH2SLC6A5KDM4ELMNA
SCHEMBL4422440 0.86 SLC6A9 (0.73) SLC6A9KCNH2SLC6A5LMNASMN1; SMN2
SCHEMBL5042096 0.85 SLC6A9 (0.71) SLC6A9KCNH2SLC6A5
SCHEMBL5038252 0.85 SLC6A9 (0.72) SLC6A9KCNH2SLC6A5GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1867554-B Piperazine with ortho-substituted phenyl and its use as GLYT1 inhibitors HOFFMANN LA ROCHE 2011-07-06 CN disclosed
EP-1656361-B1 PIPERAZINE WITH OR-SUBSTITUTED PHENYL GROUP AND THEIR USE AS GLYT1 INHIBITORS HOFFMANN LA ROCHE (CH) 2008-01-02 EP disclosed
CN-1867554-A Piperazine with ortho-substituted phenyl and its use as GLYT1 inhibitors HOFFMANN LA ROCHE (CH) 2006-11-22 CN disclosed